AceRNA specializes in the development of patient-centric novel genetic therapies based on evidence-based drug-discovery process.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Kyoto
State: Kyoto
Zip:
Country: Japan
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Angel Round | 2 | - |
Hidetoshi Takano Hirofumi Miki Hidetoshi Takano Hirofumi Miki |
10/2019 | Series A | 2 | $1.9M |
Kyoto University Innovation Capital SMBC Venture Capital Kyoto University Innovation Capital SMBC Venture Capital |
11/2018 | Seed Round | 1 | $702.8k |
Kyoto University Innovation Capital Kyoto University Innovation Capital |
1/2020 | Angel Round | 2 | - |
Hidetoshi Takano Hirofumi Miki Hidetoshi Takano Hirofumi Miki |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|